Skip to main content

Advertisement

SpringerLink
Log in

Flow Cytometry Evaluation of the T-Cell ReceptorVβ Repertoire Among HIV-1 Infected Individuals Before and After Antiretroviral Therapy

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

HIV-1 infection leads to serious impairment of the immune system and perturbations in the T cell receptor Vβ repertoire are also described. Immune reconstitution can be potentially achieved in response to HAART. In the present study 10 patients were investigated for the Vβ pattern expression before and after six months of HAART. TCR were analyzed for T CD4+ and CD8+ subsets, separately, by flow cytometry, using a monoclonal antibody set of 24 different Vβ chains. Compared to eight Brazilian healthy controls, no differences in Vβ pattern of expression was observed for patients before or on antiretroviral therapy. Some chains such as Vβ 3, 14, 16, 20 and 21.3 were over utilized by both T subsets, independently of HIV infection and/or antiretroviral treatment, differing from the ones described for individuals of other nationalities. However, when each patient was taken individually, particular alterations were detected for the Vβ gene usage, compared to controls, for all individuals. After treatment, significant Vβ usage changes were observed for seven patients. One or more chains on both T subsets were engaged in this process, defining a preferential oligoclonal profile for TCR repertoire distribution, after HAART. Although no pattern of specific Vβ changes was detected in the circulating T cells, we cannot exclude that differential immune responses to HIV or other important antigens are being focused by these cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Soudeyns H, Pantaleo G: The moving target: mechanisms of HIV persistence during primary infection. Immunol Today 20:446–450, 1999

    Google Scholar 

  2. Graziosi C, Soudeyns H, Rizzardi GP, Bart PA, Chapuis A, Pantaleo G: Immunopathogenesis of HIV infection. AIDS Res Hum Retroviruses Suppl 2:S135–S142, 1998

    Google Scholar 

  3. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68:4650–4655, 1994

    Google Scholar 

  4. Moore JP, Cao Y, Ho DD, Koup RA: Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1. J Virol 68:5142–5155, 1994

    Google Scholar 

  5. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC: Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. New Engl J Med 26(332):228–232, 1995

    Google Scholar 

  6. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, Demarest JF, Montefiori D, Orenstein JM, Fox C, Schrager LK, Margolick JB, Buchbinder S, Giorgi JV, Fauci AS: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. New Engl J Med 26(332):209–216, 1995

    Google Scholar 

  7. Haynes BF, Pantaleo G, Fauci AS: Toward an understanding of the correlates of protective immunity to HIV infection. Science 271:324–328, 1996

    Google Scholar 

  8. Pantaleo G, Fauci AS: New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 13:487–512, 1995

    Google Scholar 

  9. Propato A, Schiaffella E, Vicenzi E, Francavilla V, Baloni L, Paroli M, Finocchi L, Tanigaki N, Ghezzi S, Ferrara R, Chesnut R, Livingston B, Sette A, Paganelli R, Aiuti F, Poli G, Barnaba V: Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity. Hum Immunol 62:561–576, 2001

    Google Scholar 

  10. Bodman-Smith MD, Williams I, Johnstone R, Boylston A, Lydyard PM, Zumla A. T cell receptor usage in patients with non-progressing HIV infection. Clin Exp Immunol 130:115–120, 2002

    Article  Google Scholar 

  11. Pantaleo G, Demarest JF, Soudeyns H, Graziosi C, Denis F, Adelsberger JW, Borrow P, Saag MS, Shaw GM, Sekaly RP, Fauci AS: Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370:463–467, 1994

    Google Scholar 

  12. Pantaleo G, Demarest JF, Schacker T, Vaccarezza M, Cohen OJ, Daucher M, Graziosi C, Schnittman SS, Quinn TC, Shaw GM, Perrin L, Tambussi G, Lazzarin A, Sekaly RP, Soudeyns H, Corey L, Fauci AS: The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci USA 94:254–258, 1997

    Google Scholar 

  13. Chen ZW, Shen L, Regan JD, Kou Z, Ghim SH, Letvin NL: The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes in rhesus monkeys. J Immunol 156:1469–1475, 1996

    Google Scholar 

  14. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New Engl J Med 338:853–860, 1998

    Google Scholar 

  15. Valdez H, Chowdhry TK, Asaad R, Woolley IJ, Davis T, Davidson R, Beinker N, Gripshover BM, Salata RA, McComsey G, Weissman SB, Lederman MM: Changing spectrum of mortality due to human immunodeficiency virus: Analysis of 260 deaths during 1995–1999. Clin Infect Dis 32:1487–1493, 2001

    Google Scholar 

  16. Collier AC, Coombs RW, Schoenfeld DA, Bassett RL, Timpone J, Baruch A, Jones M, Facey K, Whitacre C, McAuliffe VJ, Friedman HM, Merigan TC, Reichman RC, Hooper C, Corey L: Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. New Engl J Med 334:1011–1017, 1996

    Google Scholar 

  17. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112–116, 1997

    Google Scholar 

  18. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, Emini EA, Chodakewitz JA: Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. New Engl J Med 337:734–739, 1997

    Google Scholar 

  19. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ Jr, Feinberg JE, Balfour HH Jr, Deyton LR, Chodakewitz JA, Fischl MA: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. New Engl J Med 337:725–733, 1997

    Google Scholar 

  20. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB: Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 11:1731–1738, 1997

    Google Scholar 

  21. Egger M, Hirschel B, Francioli P, Sudre P, Wirz M, Flepp M, Rickenbach M, Malinverni R, Vernazza P, Battegay M: Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. Swiss HIV Cohort Study. BMJ 315:1194–1199, 1997

    Google Scholar 

  22. Ledergerber B, Telenti A, Egger M: Risk of HIV related Kaposi’s sarcoma and non-Hodgkin’s lymphoma with potent antiretroviral therapy: Prospective cohort study. Swiss HIV Cohort Study. BMJ 319:23–24, 1999

    Google Scholar 

  23. Pakker NG, Notermans DW, de Boer RJ, Roos MT, de Wolf F, Hill A, Leonard JM, Danner SA, Miedema F, Schellekens PT: Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nat Med 4:208–214, 1998

    Google Scholar 

  24. Bisset LR, Cone RW, Huber W, Battegay M, Vernazza PL, Weber R, Grob PJ, Opravil M: Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study. AIDS 12:2115–2123, 1998

    Google Scholar 

  25. Bouscarat F, Levacher M, Landman R, Muffat-Joly M, Girard PM, Saimot AG, Brun-Vezinet F, Sinet M: Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. AIDS 12:1267–1273, 1998

    Google Scholar 

  26. Connick E, Lederman MM, Kotzin BL, Spritzler J, Kuritzkes DR, St Clair M, Sevin AD, Fox L, Chiozzi MH, Leonard JM, Rousseau F, D’Arc Roe J, Martinez A, Kessler H, Landay A: Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J Infect Dis 181:358–363, 2000

    Google Scholar 

  27. Soudeyns H, Campi G, Rizzardi GP, Lenge C, Demarest JF, Tambussi G, Lazzarin A, Kaufmann D, Casorati G, Corey L, Pantaleo G: Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality. Blood 95:1743–1751, 2000

    Google Scholar 

  28. Plana M, Garcia F, Gallart T, Miro JM, Gatell JM: Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease. Immunology Study Group of Spanish EARTH-1 Study. Lancet 352:1194–1195, 1998

    Google Scholar 

  29. Pontesilli O, Kerkhof-Garde S, Notermans DW, Foudraine NA, Roos MT, Klein MR, Danner SA, Lange JM, Miedema F: Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy. J Infect Dis 180:76–86, 1999

    Google Scholar 

  30. Al-Harthi L, Siegel J, Spritzler J, Pottage J, Agnoli M, Landay A: Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease. AIDS 14:761–770, 2000

    Google Scholar 

  31. Haslett PA, Nixon DF, Shen Z, Larsson M, Cox WI, Manandhar R, Donahoe SM, Kaplan G: Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy. J Infect Dis 181:1264–1272, 2000

    Google Scholar 

  32. Ruiz L, Martinez-Picado J, Romeu J, Paredes R, Zayat MK, Marfil S, Negredo E, Sirera G, Tural C, Clotet B: Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression. AIDS 14:397–403, 2000

    Google Scholar 

  33. MacIsaac C, Curtis N, Cade J, Visvanathan K: Rapid analysis of the Vbeta repertoire of CD4 and CD8 T lymphocytes in whole blood. J Immunol Methods 283:9–15, 2003

    Google Scholar 

  34. Choi YW, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J: Interaction of Staphylococcus aureus toxin “superantigens” with human T cells. Proc Natl Acad Sci USA 86:8941–8945, 1989

    Google Scholar 

  35. Malhotra U, Spielman R, Concannon P. Variability in T cell receptor V beta gene usage in human peripheral blood lymphocytes. Studies of identical twins, siblings, and insulin-dependent diabetes mellitus patients. J Immunol 149:1802–1808, 1992

    Google Scholar 

  36. Cossarizza A, Kahan M, Ortolani C, Franceschi C, Londei M: Preferential expression of V beta 6.7 domain on human peripheral CD4+ T cells. Implication for positive selection of T cells in man. Eur J Immunol 21:1571–1574, 1991

    Google Scholar 

  37. Grunewald J, Janson CH, Wigzell H: Biased expression of individual T cell receptor V gene segments in CD4+ and CD8+ human peripheral blood T lymphocytes. Eur J Immunol 21:819–822, 1991

    Google Scholar 

  38. Clarke GR, Humphrey CA, Lancaster FC, Boylston AW: The human T cell antigen receptor repertoire: Skewed use of V beta gene families by CD8+ T cells. Clin Exp Immunol 96:364–369, 1994

    Google Scholar 

  39. Muraro PA, Jacobsen M, Necker A, Nagle JW, Gaber R, Sommer N, Oertel WH, Martin R, Hemmer B: Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vbeta analysis. J Immunol Methods 246:131–143, 2000

    Google Scholar 

  40. van den Beemd R, Boor PP, van Lochem EG, Hop WC, Langerak AW, Wolvers-Tettero IL, Hooijkaas H, van Dongen JJ: Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 40:336–345, 2000

    Google Scholar 

  41. Melenhorst JJ, Eniafe R, Follmann D, Nakamura R, Kirby M, Barrett AJ: Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndrome. Br J Haematol 119:97–105, 2002

    Google Scholar 

  42. Shigematsu M, Nagai S, Mikuniya T, Izumi T, Wigzell H, Eklund AG, Grunewald J: T cell receptor (TCR) V gene segment use in HLA-typed Japanese healthy subjects. Clin Exp Immunol 103:149–154, 1996

    Google Scholar 

  43. Esin S, Gul A, Hodara V, Jeddi-Tehrani M, Dilsen N, Konice M, Andersson R, Wigzell H: Peripheral blood T cell expansions in patients with Behcet’s disease. Clin Exp Immunol 107:520–527, 1997

    Google Scholar 

  44. Akolkar PN, Gulwani-Akolkar B, Pergolizzi R, Bigler RD, Silver J: Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J Immunol 150:2761–2773, 1993

    Google Scholar 

  45. Akolkar PN, Gulwani-Akolkar B, Robinson MA, Silver J: The influence of non-HLA genes on the human T-cell receptor repertoire. Scand J Immunol 42:248–256, 1995

    Google Scholar 

  46. Silver J, Gulwani-Akolkar B, Akolkar PN: The influence of genetics, environment, and disease state on the human T-cell receptor repertoire. Ann N Y Acad Sci 756:28–52, 1995

    Google Scholar 

  47. Mion M, Indraccolo S, Feroli F, Minuzzo S, Masiero S, Zamarchi R, Barelli A, Borri A, Chieco-Bianchi L, Amadori A: TCR expression and clonality analysis in peripheral blood and lymph nodes of HIV-infected patients. Hum Immunol 57:93–103, 1997

    Google Scholar 

  48. Pantaleo G, Soudeyns H, Demarest JF, Vaccarezza M, Graziosi C, Paolucci S, Daucher MB, Cohen OJ, Denis F, Biddison WE, Sekaly RP, Fauci AS: Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc Natl Acad Sci USA 94:9848–9853, 1997

    Google Scholar 

  49. Soudeyns H, Rebai N, Pantaleo GP, Ciurli C, Boghossian T, Sekaly RP, Fauci AS: The T cell receptor V beta repertoire in HIV-1 infection and disease. Semin Immunol 5:175–185, 1993

    Google Scholar 

  50. Giovannetti A, Pierdominici M, Marziali M, Mazzetta F, Caprini E, Russo G, Bugarini R, Bernardi ML, Mezzaroma I, Aiuti F: Persistently biased T-cell receptor repertoires in HIV-1-infected combination antiretroviral therapy-treated patients despite sustained suppression of viral replication. J Acquir Immune Defic Syndr 34:140–154, 2003

    Google Scholar 

  51. Cossarizza A, Poccia F, Agrati C, D’Offizi G, Bugarini R, Pinti M, Borghi V, Mussini C, Esposito R, Ippolito G, Narciso P: Highly active antiretroviral therapy restores CD4+ Vbeta T-cell repertoire in patients with primary acute HIV infection but not in treatment-naive HIV+ patients with severe chronic infection. J Acquir Immune Defic Syndr 35:213–222, 2004

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of AIDS and Molecular Immunology, Department of Immunology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil

    Carmem Beatriz Wagner Giacoia-Gripp & Mariza Gonçalves Morgado

  2. Department of Micro-Immuno-Parasitology, Evandro Chagas Clinical Research Institute, FIOCRUZ, Rio de Janeiro, Brazil

    Ivan Neves Jr.

  3. Department of Infectious Diseases, Evandro Chagas Clinical Research Institute, FIOCRUZ, Rio de Janeiro, RJ, Brazil

    Maria Clara Galhardo

  4. Laboratory of AIDS and Molecular Immunology, Department of Immunology, Oswaldo Cruz Institute, FIOCRUZ, Avenue Brasil 4365, Leonidas Deane Building, Room 413, Rio de Janeiro, 21045-900, Brazil

    Mariza Gonçalves Morgado

Authors
  1. Carmem Beatriz Wagner Giacoia-Gripp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ivan Neves Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Clara Galhardo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mariza Gonçalves Morgado
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mariza Gonçalves Morgado.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giacoia-Gripp, C.B.W., Neves, I., Galhardo, M.C. et al. Flow Cytometry Evaluation of the T-Cell ReceptorVβ Repertoire Among HIV-1 Infected Individuals Before and After Antiretroviral Therapy. J Clin Immunol 25, 116–126 (2005). https://doi.org/10.1007/s10875-005-2817-z

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-005-2817-z

Keywords

Search

Navigation